Cullen/Frost Bankers, Inc. Jazz Pharmaceuticals PLC Transaction History

Cullen/Frost Bankers, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$126.59 - $161.18 $1,265 - $1,611	10 New	10 $1,000
Q1 2022 May 09, 2022	SELL	$129.64 - $160.7 $777 - $964	-6 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$128.64 - $184.79 $385 - $554	-3 Reduced 33.33%	6 $1,000
Q2 2021 Aug 05, 2021	BUY	$160.2 - $186.42 $1,441 - $1,677	9 New	9 $2,000
Q2 2019 Aug 01, 2019	SELL	$125.55 - $144.48 $82,109 - $94,489	-654 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$121.81 - $142.95 $79,663 - $93,489	654 New	654 $93,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.